Skip to main content
Erschienen in: World Journal of Surgery 12/2020

14.08.2020 | Original Scientific Report

Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors

verfasst von: Norifumi Harimoto, Kenichiro Araki, Kouki Hoshino, Ryo Muranushi, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Hiroyasu Tomonaga, Tetsuya Higuchi, Yoshito Tsushima, Hayato Ikota, Ken Shirabe

Erschienen in: World Journal of Surgery | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this study was to identify whether diffusion-weighted magnetic resonance imaging (DW-MRI) can predict the malignant behavior of preoperative well-differentiated pancreatic neuroendocrine tumors (PanNETs).

Method

Forty patients with PanNETs who underwent pancreatectomy were enrolled in this study. The apparent diffusion coefficient (ADC) values were measured. Clinicopathological factors were compared in patients with high ADC and low ADC values and in patients with and without lymph node metastasis (LNM).

Result

The low ADC group was significantly associated with higher Ki-67 index, higher mitotic count, larger tumor size, higher rate of LNM, and venous invasion. In patients with low ADC values, the incidence of LNMs was 33.3%. In patients with high ADC values, there were no patients with LNM being 0%. A significant negative correlation was found between the mean ADC values and the Ki-67 index and between the mean ADC values and the mitotic count. In multivariate analysis, neural invasion and mean ADC values ≤ 1458 were independent predictors of LNM.

Conclusion

ADC values obtained using DW-MRI in the preoperative assessment of patients with PanNETs might be a useful predictor of malignant potential, especially LNM.
Literatur
1.
Zurück zum Zitat Fesinmeyer MD, Austin MA, Li CI, De Roos AJ et al (2005) Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev 14:1766–1773CrossRef Fesinmeyer MD, Austin MA, Li CI, De Roos AJ et al (2005) Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev 14:1766–1773CrossRef
2.
Zurück zum Zitat Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072CrossRef Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072CrossRef
3.
Zurück zum Zitat Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system, 4th edn. International Agency for Research on Cancer, Lyon Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system, 4th edn. International Agency for Research on Cancer, Lyon
4.
Zurück zum Zitat Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumours of endocrine organs, 4th edn. International Agency for Research on Cancer, Lyon, p 355 Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumours of endocrine organs, 4th edn. International Agency for Research on Cancer, Lyon, p 355
5.
Zurück zum Zitat Harimoto N, Hoshino K, Muranushi R et al (2019) Significance of lymph node metastasis in resectable well-differentiated pancreatic neuroendocrine tumor. Pancreas 48(7):943–947CrossRef Harimoto N, Hoshino K, Muranushi R et al (2019) Significance of lymph node metastasis in resectable well-differentiated pancreatic neuroendocrine tumor. Pancreas 48(7):943–947CrossRef
6.
Zurück zum Zitat Harimoto N, Hoshino K, Muranushi R et al (2019) Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages. Pancreatol 19(6):897–902CrossRef Harimoto N, Hoshino K, Muranushi R et al (2019) Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages. Pancreatol 19(6):897–902CrossRef
7.
Zurück zum Zitat Weynand B, Borbath I, Bernard V et al (2014) Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathol 25:389–395 Weynand B, Borbath I, Bernard V et al (2014) Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathol 25:389–395
8.
Zurück zum Zitat Fujimori N, Osoegawa T, Lee L et al (2016) Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol 51(2):245–252CrossRef Fujimori N, Osoegawa T, Lee L et al (2016) Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol 51(2):245–252CrossRef
9.
Zurück zum Zitat Sugimoto M, Takagi T, Hikichi T et al (2015) Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading. World J Gastroenterol 21(26):8118–8124CrossRef Sugimoto M, Takagi T, Hikichi T et al (2015) Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading. World J Gastroenterol 21(26):8118–8124CrossRef
10.
Zurück zum Zitat Garces-Descovich A, Morrison TC, Beker K et al (2019) DWI of pancreatic ductal adenocarcinoma: a pilot study to estimate the correlation with metastatic disease potential and overall survival. AJR Am J Roentgenol 212(2):323–331CrossRef Garces-Descovich A, Morrison TC, Beker K et al (2019) DWI of pancreatic ductal adenocarcinoma: a pilot study to estimate the correlation with metastatic disease potential and overall survival. AJR Am J Roentgenol 212(2):323–331CrossRef
11.
Zurück zum Zitat Yamada S, Morine Y, Imura S, et al (2020) Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 27(7):388–395 Yamada S, Morine Y, Imura S, et al (2020) Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 27(7):388–395
12.
Zurück zum Zitat Schmeel FC, Simon B, Luetkens JA et al (2017) Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol 143(8):1531–1541CrossRef Schmeel FC, Simon B, Luetkens JA et al (2017) Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol 143(8):1531–1541CrossRef
13.
Zurück zum Zitat Kitajima K, Yamano T, Fukushima K et al (2016) Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma. Eur J Radiol 85(5):943–949CrossRef Kitajima K, Yamano T, Fukushima K et al (2016) Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma. Eur J Radiol 85(5):943–949CrossRef
14.
Zurück zum Zitat Zong RL, Geng L, Wang X et al (2019) Diagnostic performance of apparent diffusion coefficient for prediction of grading of pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Pancreas 48(2):151–160CrossRef Zong RL, Geng L, Wang X et al (2019) Diagnostic performance of apparent diffusion coefficient for prediction of grading of pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Pancreas 48(2):151–160CrossRef
15.
Zurück zum Zitat Paudyal B, Paudyal P, Tsushima Y et al (2010) The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol 83(988):336–343CrossRef Paudyal B, Paudyal P, Tsushima Y et al (2010) The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol 83(988):336–343CrossRef
16.
Zurück zum Zitat Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 30(2):249–255CrossRef Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 30(2):249–255CrossRef
17.
Zurück zum Zitat Hu Y, Rao S, Xu X et al (2018) Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features. Abdom Radiol (NY) 43(11):3016–3024CrossRef Hu Y, Rao S, Xu X et al (2018) Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features. Abdom Radiol (NY) 43(11):3016–3024CrossRef
18.
Zurück zum Zitat De Robertis R, Maris B, Cardobi N et al (2018) Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 28(6):2582–2591CrossRef De Robertis R, Maris B, Cardobi N et al (2018) Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 28(6):2582–2591CrossRef
19.
Zurück zum Zitat Guo C, Zhuge X, Chen X et al (2017) Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors. Oncol Lett 13(6):4141–4146CrossRef Guo C, Zhuge X, Chen X et al (2017) Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors. Oncol Lett 13(6):4141–4146CrossRef
20.
Zurück zum Zitat Lotfalizadeh E, Ronot M, Wagner M et al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27(4):1748–1759CrossRef Lotfalizadeh E, Ronot M, Wagner M et al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27(4):1748–1759CrossRef
21.
Zurück zum Zitat Pereira JA, Rosado E, Bali M et al (2015) Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade. Abdom Imaging 40(8):3122–3128CrossRef Pereira JA, Rosado E, Bali M et al (2015) Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade. Abdom Imaging 40(8):3122–3128CrossRef
22.
Zurück zum Zitat Sun HT, Zhang SL, Liu K, Zhou JJ et al (2019) MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection. J Magn Reson Imaging 50(2):397–409CrossRef Sun HT, Zhang SL, Liu K, Zhou JJ et al (2019) MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection. J Magn Reson Imaging 50(2):397–409CrossRef
23.
Zurück zum Zitat Yamamoto Y, Okamura Y, Uemura S et al (2017) Vascularity and tumor size are significant predictors for recurrence after resection of a pancreatic neuroendocrine tumor. Ann Surg Oncol 24(8):2363–2370CrossRef Yamamoto Y, Okamura Y, Uemura S et al (2017) Vascularity and tumor size are significant predictors for recurrence after resection of a pancreatic neuroendocrine tumor. Ann Surg Oncol 24(8):2363–2370CrossRef
24.
Zurück zum Zitat Okabe H, Hashimoto D, Chikamoto A et al (2017) Shape and enhancement characteristics of pancreatic neuroendocrine tumor on preoperative contrast-enhanced computed tomography may be prognostic indicators. Ann Surg Oncol 24(5):1399–1405CrossRef Okabe H, Hashimoto D, Chikamoto A et al (2017) Shape and enhancement characteristics of pancreatic neuroendocrine tumor on preoperative contrast-enhanced computed tomography may be prognostic indicators. Ann Surg Oncol 24(5):1399–1405CrossRef
25.
Zurück zum Zitat Hashim YM, Trinkaus KM, Linehan DC et al (2014) Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 259:197–203CrossRef Hashim YM, Trinkaus KM, Linehan DC et al (2014) Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 259:197–203CrossRef
26.
Zurück zum Zitat Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinol 103:153–171CrossRef Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinol 103:153–171CrossRef
27.
Zurück zum Zitat Oberg K, Knigge U, Kwekkeboom D et al (2012) ESMO guidelines working group neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:124–130CrossRef Oberg K, Knigge U, Kwekkeboom D et al (2012) ESMO guidelines working group neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:124–130CrossRef
28.
Zurück zum Zitat Conrad C, Kutlu OC, Dasari A et al (2016) Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg 20:1966–1974CrossRef Conrad C, Kutlu OC, Dasari A et al (2016) Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg 20:1966–1974CrossRef
29.
Zurück zum Zitat Chouliaras K, Newman NA, Shukla M et al (2018) Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. J Surg Oncol 118:416–421CrossRef Chouliaras K, Newman NA, Shukla M et al (2018) Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. J Surg Oncol 118:416–421CrossRef
30.
Zurück zum Zitat Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490–500CrossRef Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490–500CrossRef
31.
Zurück zum Zitat Sallinen VJ, Le Large TYS, Tieftrunk E et al (2018) Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors: a multi-institutional study. HPB 20:251–259CrossRef Sallinen VJ, Le Large TYS, Tieftrunk E et al (2018) Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors: a multi-institutional study. HPB 20:251–259CrossRef
32.
Zurück zum Zitat Fischer L, Bergmann F, Schimmack S et al (2014) Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 101:1405–1412CrossRef Fischer L, Bergmann F, Schimmack S et al (2014) Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 101:1405–1412CrossRef
33.
Zurück zum Zitat Tsutsumi K, Ohtsuka T, Fujino M et al (2014) Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci 21:418–425CrossRef Tsutsumi K, Ohtsuka T, Fujino M et al (2014) Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci 21:418–425CrossRef
34.
Zurück zum Zitat Wong J, Fulp WJ, Strosberg JR et al (2014) Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience. Am J Surg 208:775–780CrossRef Wong J, Fulp WJ, Strosberg JR et al (2014) Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience. Am J Surg 208:775–780CrossRef
Metadaten
Titel
Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors
verfasst von
Norifumi Harimoto
Kenichiro Araki
Kouki Hoshino
Ryo Muranushi
Kei Hagiwara
Norihiro Ishii
Mariko Tsukagoshi
Takamichi Igarashi
Akira Watanabe
Norio Kubo
Hiroyasu Tomonaga
Tetsuya Higuchi
Yoshito Tsushima
Hayato Ikota
Ken Shirabe
Publikationsdatum
14.08.2020
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 12/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05736-3

Weitere Artikel der Ausgabe 12/2020

World Journal of Surgery 12/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.